Glaukos Corp (GKOS) Shares Outstanding 2012–TTM

Name: Glaukos Corp (GKOS) shares outstanding history 2012-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-07-31

Glaukos Corp annual shares outstanding for fiscal TTM was 58 million shares, an increase of 1.8% from 57 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

GKOS Annual Shares Outstanding

Shares Outstanding (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Shares Outstanding (M)	58M	57M	53M	48M	47M	46M	44M	41M	35M	34M	36M	17M	25M	—	2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GKOS Quarterly Shares Outstanding

Shares Outstanding (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Shares Outstanding (M)	58M	58M	58M	57M	57M	57M	56M	55M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Shares Outstanding at Comparable Companies

SNN Shares Outstanding — Smith & Nephew SNATS Inc
BIO Shares Outstanding — Bio-Rad Laboratories Inc
GMED Shares Outstanding — Globus Medical
BIO.B Shares Outstanding — Bio-Rad Laboratories Inc
BRKR Shares Outstanding — Bruker Corporation

More GKOS metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All GKOS financial statements → Interactive GKOS charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.